# data[].attributes.body
The iLet pancreas monitor is designed to monitor blood glucose levels continuously while adjusting insulin doses according to glucose numbers and trends.

This device claims to complete insulin calculations for you so that patients do not have to rely on exact carb counting.

The device only requires your weight and you can begin!

# data[].attributes.body
Some of pros of this medical device is that it can detect dangerous out of range glucose numbers and adjust insulin dose.

Another pro is that this device can read glucose numbers during the evening and prevent dangerously low glucose numbers. This could lead to prevention of a hypoglycemic event.

This could also be very helpful for those who may work in a face paced job and may not have the time to continuously check their glucose levels.

# data[].attributes.body
Some cons of this device is that it could lead to incorrect glucose numbers. This could be from user error or faultly equipment.

Another con, there could be a miscalculation of the basal rate from the machine. This could lead a hypo/hyperglycemic event.

# data[].attributes.body
Andrew- Activator
Abraham- Arranger
Carter- Communication
Fernando- Focus
William- Woo

I picked these individuals as they all contribute to the team with strengths that are not listed in my Top 5 (Input, Connectedness, Empathy, Futuristic, Maximizer).

Andrew and Abraham are excellent to start out project and bring it to life. Carter and Fernando will add extra help by adding ways to communicate our life saving gadget. William will create positive energy and hype for our project to be accepted.

# data[].attributes.body
Hastings, C. (2023, June 8). iLet bionic pancreas cleared by FDA . Medgadget. https://www.medgadget.com/2023/06/ilet-bionic-pancreas-cleared-by-fda.html

The adult ILET is an automated insulin delivery system. Beta Bionics. (2023, May 19). https://www.betabionics.com/ilet-bionic-pancreas/ilet-adults/

# data[].attributes.attachment_link.readable_text
The iLet Bionic Pancreas for use by type 1 diabetes patients has been cleared by the FDA and is now available commercially. The device is offered by Beta Bionics, a medtech company based in Massachusetts and California, but the underlying technology originally developed by researchers at Boston University. The system can be paired with a Bluetooth glucose monitor to deliver personalized insulin dosing every five minutes, and calculates doses based on past and current glucose levels and its experience of how the user reacted to previous insulin doses. The technology has a personal origin story, as one of the researchers drove its development based on his experiences caring for his son with type 1 diabetes.

Controlling blood glucose levels in type 1 diabetes patients is a 24/7, 365 days a year kind of job, with an ongoing risk of dangerously low blood sugar levels occurring. This is particularly challenging at night, when sleep is the preferred option, and waking regularly to check that things are ok is difficult. This challenge inspired the creation of this technology, as one of the researchers cared for their son with type 1 diabetes on a nightly basis, and grew to appreciate these risks and the potential that this technology had.

"Sleeping is the scariest part of all this," said Ed Damiano, a researcher involved in the project, who drove the research forward based on his experiences with his son. "It's what put this project on a high-speed rail. It's a very scary prospect that blood sugars could go low at night. When you're sleeping, you're checked out-you don't want to check out permanently."

The iLet Bionic Pancreas has been cleared for people aged six and up with type 1 diabetes. The company reports that all users have to do is enter their weight into the system, and then the device will begin to automatically regulate blood glucose levels, learning as it goes. The device is small enough to sit in a pocket or be clipped to a strap or belt.

The FDA clearance decision was likely helped by a study published by the researchers in September 2022 that showed the bionic pancreas was better than the current standard of care at helping type 1 diabetes patients (both children and adults) to maintain optimal blood glucose levels.

"Today's action will provide the type 1 diabetes community with additional options and flexibilities for diabetes management and may help to broaden the reach of AID [automated insulin dosing] technology," said Jeff Shuren, director of the FDA's Center for Devices and Radiological Health. "The FDA is committed to advancing new device innovation that can improve the health and quality of life for people living with chronic diseases that require day-to-day maintenance, like diabetes, through precision medicine approaches."

Product page: iLet Bionic Pancreas...

Flashback: Beta Bionics iLet Bionic Pancreas System Gets FDA Breakthrough Designation

Via: Boston University

# data[].attributes.attachment_link.description
The iLet Bionic Pancreas for use by type 1 diabetes patients has been cleared by the FDA and is now available commercially. The device is offered by Beta Bionics, a medtech company based in Massachusetts and California, but the underlying technology originally developed by researchers at Boston University.

# data[].attributes.attachment_link.title
The Adult iLet is an automated insulin delivery system

# data[].attributes.attachment_link.description
Safety Information - The iLet Bionic Pancreas System is indicated for use by people with type 1 diabetes 6 years of age and older. The iLet Bionic Pancreas requires prescription by a physician. Refer to the iLet Bionic Pancreas System User Guide at www.betabionics.com/resouces/user-guides, or for complete safety information including indications, contraindications, warnings, cautions, compatible devices, compatible drugs and instructions, refer to www.betabionics.com/resources/safety.